The Food and Drug Administration (FDA) is hosting a joint public advisory committee meeting on February 5, 2025. This meeting involves the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. The focus will be on discussing the outcomes of studies related to the risks associated with long-term use of extended-release/long-acting opioid analgesics. The FDA has opened a public comment docket, which will close on February 4, 2025, allowing individuals to submit their views electronically or by mail.
Simple Explanation
The FDA is having a big meeting to talk about some strong pain medicines and whether they are safe when used for a long time. Before the meeting, they're asking people to share their thoughts about these medicines online or through the mail.